FLNA — Filana Therapeutics Share News
0.000.00%
Last trade - 00:00Brief: Cassava Sciences Says Engaging With DOJ And SEC Regarding Ongoing Investigations Into Co & Two Senior Employees
Cassava Sciences forms panel after probes by U.S. regulators; shares drop
Cassava Sciences forms internal panel after U.S. regulatory probe into two employees (updated)
Cassava Sciences forms internal committee after probes by U.S. regulators into two employees
US professor charged with manipulating data for Alzheimer’s drug trial (updated)
Cassava Sciences Inc reports results for the quarter ended in March - Earnings Summary
Brief: Cassava Sciences Q1 Basic EPS USD 0.58
Cassava Sciences Inc expected to post a loss of 46 cents a share - Earnings Preview
Brief: Cassava Sciences Completes Interim Safety Review Of Oral Simufilam On-Going Phase 3 Trials
Cassava Sciences Inc reports results for the quarter ended in December - Earnings Summary
Brief: Cassava Sciences Q4 Basic EPS USD -0.5
Cassava Sciences Inc expected to post a loss of 52 cents a share - Earnings Preview
Brief: Cassava Sciences Appoints Three New Members To Its Board Of Directors
Brief: Cassava Sciences Q3 Basic EPS USD -0.61
Brief: Cassava Sciences Completes Enrollment for Pivotal Phase 3 Program of Simufilam in Alzheimer’s Disease
Cassava Sciences Inc expected to post a loss of 77 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Silver miners, Instacart, Incyte
U.S. STOCKS ON THE MOVE-Energy sector, Sigma Additive Solutions, Newmont Corp
U.S. STOCKS ON THE MOVE-T2 Biosystems, Dollar General, Wells Fargo